Learning Objectives:

• Enhance understanding of CINV classification—acute, delayed, and anticipatory types—along with their pathophysiology and variability in patient experiences
• Emphasize the importance of proactive management for highly emetogenic agents
• Raise awareness of antiemetic guidelines and evidence-based best practices for effective CINV prevention and management
• Promote collaboration within multidisciplinary teams to improve CINV management strategies and advance patient care outcomes
• Gain valuable insights into patients’ experiences to better understand the personal and emotional impact of delayed nausea, as well as barriers to effective symptom control 

Agenda:

• Introduction – Prof. Maryam Lustberg (Chair)
• Understanding CINV: Pathophysiology, Risk Factors & Patient Variability – Dr. George Dranitsaris
• Best Practices in CINV Prophylaxis: Integrating Guidelines & MDT Strategies – Dr. Rudolph M. Navari
• The Patient Perspective: Living with Delayed Nausea - Abigail Johnston, JD (Patient Partner)
• Q & A panel discussion

This webinar was supported by an independent educational grant from Daiichi Sankyo.